Search

Your search keyword '"Lerche, Holger"' showing total 1,533 results

Search Constraints

Start Over You searched for: Author "Lerche, Holger" Remove constraint Author: "Lerche, Holger"
1,533 results on '"Lerche, Holger"'

Search Results

151. An identical‐by‐descent novel splice‐donor variant in PRUNE1 causes a neurodevelopmental syndrome with prominent dystonia in two consanguineous Sudanese families

153. Heterozygous variants in KCNC2 cause a broad spectrum of epilepsy phenotypes associated with characteristic functional alterations

155. Real-life survey of pitfalls and successes of precision medicine in genetic epilepsies

156. Loss-of-function variants in the KCNQ5 gene are associated with genetic generalized epilepsies

158. Axon initial segment dysfunction in a mouse model of genetic epilepsy with febrile seizures plus

163. DEPDC5 mutations in genetic focal epilepsies of childhood

166. Heterozygous UCHL1loss-of-function variants cause a neurodegenerative disorder with spasticity, ataxia, neuropathy, and optic atrophy

168. A pharmacogenomic assessment of psychiatric adverse drug reactions to levetiracetam.

169. Gain-of-function variants in GABRD reveal a novel pathway for neurodevelopmental disorders and epilepsy.

170. Epilepsy, hippocampal sclerosis and febrile seizures linked by common genetic variation around SCN1A

171. GLUT1 mutations are a cause of paroxysmal exertion-induced dyskinesias and induce hemolytic anemia by a cation leak

172. Epilepsy Subtype-Specific Copy Number Burden Observed in a Genome-Wide Study of 17 458 Subjects

173. Genomic and clinical predictors of lacosamide response in refractory epilepsies

186. Exon-disrupting deletions of NRXN1 in idiopathic generalized epilepsy

187. Rare exonic deletions of the RBFOX1 gene increase risk of idiopathic generalized epilepsy

189. Genome-wide association analysis of genetic generalized epilepsies implicates susceptibility loci at 1q43, 2p16.1, 2q22.3 and 17q21.32

190. The LaLiMo Trial: lamotrigine compared with levetiracetam in the initial 26 weeks of monotherapy for focal and generalised epilepsy—an open-label, prospective, randomised controlled multicenter study

192. PRRT2 Mutations are the major cause of benign familial infantile seizures

195. Episodic Ataxia Type 1 and Type 2

196. GDM

197. Genetic Hemochromatosis

198. Glycogen Synthase Deficiency

199. Enteropathy, Autoimmune, with Hemolytic Anemia and Polyendocrinopathy

200. Graft-Versus-Host Disease

Catalog

Books, media, physical & digital resources